![]() |
CrossRef Text and Data Mining |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
High Dose Intravitreal Bevacizumab for Refractory Pigment Epithelial Detachment in Age-related Macular Degeneration |
Dong Kyu Lee, Soon Hyun Kim, Yong Sung You, Oh Woong Kwon |
Korean J Ophthalmol. 2016;30(4):265-271. Published online July 21, 2016 DOI: https://doi.org/10.3341/kjo.2016.30.4.265 |
High Dose Intravitreal Bevacizumab for Refractory Pigment Epithelial Detachment in Age-related Macular Degeneration Retinal Pigment Epithelial Detachment in Age-Related Macular Degeneration Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with retinal pigment epithelial detachment in age-related macular degeneration Intravitreal bevacizumab for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration Effect of intravitreal aflibercept injection for age-related macular degeneration with a retinal pigment epithelial tear refractory to intravitreal ranibizumab injection Retinal pigment epithelial tear following intravitreal bevacizumab injection for neovascular age-related macular degeneration One-year outcome after intravitreal ranibizumab for large, serous pigment epithelial detachment secondary to age-related macular degeneration Intravitreal ranibizumab for treatment of fibrovascular pigment epithelial detachment in age-related macular degeneration Response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory ranibizumab |